Switzerland· 54634001
Ursofalk, Suspension
A ursodeoxycholic acid product, registered in Switzerland by Dr. Falk Pharma AG and dispensed under Swissmedic category B. The same ATC class is registered in 16 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Ursodeoxycholic acid is registered in 16 of 19 countries.
Countries holding a registration under ATC A05AA02 (ursodeoxycholic acid), each read from that country’s own register.
- This record: Switzerland
- 9 of them publish a price we can compare per daily dose
Ursodeoxycholic acid · ATC A05AA02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ursodeoxycholic acid costs, country by country.
Normalised to the WHO defined daily dose (0.75 g), the median price runs from $0.77 in Italy to $3.43 in Switzerland — a ×4.4 gap.
- Switzerland: $3.43 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Ursodeoxycholic acid · price per daily dose (0.75 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.43
- US United States$1.16 (acquisition cost)
- IT Italy$0.77
The record
At a glance
- Manufacturer
- Dr. Falk Pharma AG
- Country
- Switzerland (CH)
- ATC code
- A05AA02
- ATC class
- Ursodeoxycholic acid
- Defined daily dose
- 0.75 g, O
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
331 interactions on record for ursodeoxycholic acid.
Graded by severity as the source publishes them — 2 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ursodeoxycholic acid · interactions on record
331 records
Same class
Other records under A05AA02
Ursodeoxycholic acid, as other registers publish it.
- ItalyACIDO URSODESOSSICOLICORATIOPHARM GMBH
- ItalyACIDO URSODESOSSICOLICORATIOPHARM GMBH
- ItalyACIDO URSODESOSSICOLICO AUROBINDOAUROBINDO PHARMA ITALIA S.R.L.
- ItalyACIDO URSODESOSSICOLICO DOC GENERICIDOC GENERICI S.R.L.
- ItalyACIDO URSODESOSSICOLICO DOC GENERICIDOC GENERICI S.R.L.
- ItalyACIDO URSODESOSSICOLICO EGEG S.P.A.
- ItalyACIDO URSODESOSSICOLICO EGEG S.P.A.
- ItalyACIDO URSODESOSSICOLICO MYLAN GENERICSMYLAN S.P.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d4a18985-50f6-4705-b0db-e205da68e31f GET /v1/drugs/d4a18985-50f6-4705-b0db-e205da68e31f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about ursodeoxycholic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.